Biomedical Engineering Reference
In-Depth Information
75. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane,
J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, I.I.,
Thomson, J.A. (2007). Induced pluripotent stem cell lines derived from
human somatic cells,
, pp. 1917-1920.
76. Kehat, I., Kenyagin-Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein,
A., Livne, E., Binah, O., Itskovitz-Eldor, J., Gepstein, L. (2001). Human
embryonic stem cells can differentiate into myocytes with structural
and functional properties of cardiomyocytes,
Science, 318
J. Clin. Invest., 108
, pp.
407-414.
77. Mummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker, R.,
van den Brink, S., Hassink, R., van der Heyden, M., Opthof, T., Pera, M.,
de la Riviere, A.B., Passier, R., Tertoolen, L. (2003). Differentiation of
human embryonic stem cells to cardiomyocytes: role of coculture with
visceral endoderm-like cells,
, pp. 2733-2740.
78. Yang, L., Soonpaa, M.H., Adler, E.D., Roepke, T.K., Kattman, S.J., Kennedy,
M., Henckaerts, E., Bonham, K., Abbott, G.W., Linden, R.M., Field, L.J.,
Keller, G.M. (2008). Human cardiovascular progenitor cells develop
from a KDR+ embryonic-stem-cell-derived population,
Circulation, 107
Nature,
453
,
pp. 524-528.
79. Kita-Matsuo, H., Barcova, M., Prigozhina, N.,
Salomonis, N., Wei, K.,
Jacot, J.G., Nelson, B., Spiering, S., Haverslag, R., Kim, C., Talantova, M.,
Bajpai, R., Calzolari, D., Terskikh, A., McCulloch, A.D., Price, J.H., Conklin,
B.R., Chen, H.S., Mercola, M. (2009). Lentiviral vectors and protocols
for creation of stable hESC lines for fluorescent tracking and drug
resistance selection of cardiomyocytes,
, p. e5046.
80. Rust, W., Balakrishnan, T., Zweigerdt, R. (2009). Cardiomyocyte
enrichment from human embryonic stem cell cultures by selection of
ALCAM surface expression,
PLOS ONE
,
4
Regen. Med.
,
4
, pp. 225-237.
81. Hattori,
Tohyama, S., Satoh, Y.S., Yuasa, S., Li,
W., Yamakawa, H., Tanaka, T., Onitsuka, T., Shimoji, K., Ohno, Y., Egashira,
T., Kaneda, R., Murata, M., Hidaka, K., Morisaki, T., Sasaki, E., Suzuki, T.,
Sano, M., Makino, S., Oikawa, S., Fukuda, K.
F.
, Chen,
H.
, Yamashita,
H.,
(2010). Nongenetic method
for purifying stem cell-derived cardiomyocytes,
Nat. Methods, 7
, pp.
61-66.
82. Dubois, N.C., Craft, A.M., Sharma, P., Elliott, D.A., Stanley, E.G., Elefanty,
A.G., Gramolini, A., Keller, G. (2011). SIRPA is a specific cell-surface
marker for isolating cardiomyocytes derived from human pluripotent
stem cells,
, pp. 1011-1018.
83. Uosaki, H., Fukushima, H., Takeuchi, A., Matsuoka, S., Nakatsuji, N.,
Yamanaka, S., Yamashita, J.K. (2011). Efficient and scalable purification
Nat. Biotechnol., 29
Search WWH ::




Custom Search